Synaptic failure: The achilles tendon of sphingolipidoses

Area of Science:

• Neuroscience
• Genetics
• Cell Biology

Background:

• Lysosomal storage diseases (LSDs) frequently cause severe neurological symptoms, affecting over two-thirds of patients.
• Neurological dysfunction in LSDs is linked to impaired endosomal/lysosomal pathways, disrupting neuronal and glial homeostasis.
• Neurons' postmitotic nature prevents dilution of stored material, leading to cell death in advanced stages.

Purpose of the Study:

• To explore the mechanisms of neurological decline in LSDs.
• To investigate the role of synaptic deficits in early-stage LSD neuropathology.
• To identify potential molecular targets for therapeutic intervention in LSDs.

Main Methods:

• Review of existing literature on LSDs and neurological dysfunction.
• Analysis of the pathophysiology of endosomal-lysosomal pathway disruption in neurons.
• Conceptualization of "dying-back neuropathology" as a model for LSD neurological decline.

Main Results:

• Synaptic deficits, preceding overt neuronal cell death, are common in early LSD stages, especially sphingolipidoses.
• This synaptic failure represents a form of physiological death, impairing neuronal communication.
• The "dying-back" concept highlights the vulnerability of synaptic function in LSDs.

Conclusions:

• Understanding synaptic deficits in LSDs is crucial for comprehending neurological decline.
• Targeting synaptic dysfunction may offer a novel therapeutic avenue to prevent irreversible neuronal damage in LSDs.
• Protecting synaptic integrity could be key to averting the terminal stages of neurological demise in LSDs.